23andMe Sells Gene-Testing Business, Reddit Downgrade, Royal Caribbean Upgrade

On this episode of Stock Movers:

- 23andMe (MEHCQ) shares are up as the bankrupt genetic-testing firm agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The sale comes after a wave of customers and government officials demanded that 23andMe protect the genetic data it had built up over the years by collecting saliva samples from customers. Regeneron pledged to comply with 23andMe’s privacy policy, which allows customers to have their personal information deleted upon request.

- Reddit (RDDT) shares are down after the web forum operator is downgraded to equal-weight from overweight at Wells Fargo, with analysts saying that recent user disruptions are likely to be more permanent as Google “more aggressively” implements AI features in search. Wells Fargo analysts say change in search user behavior is accelerating with Google likely to integrate full AI search capabilities soon

- Royal Caribbean Cruises Ltd. (RCL) shares are down. However, the company regained its investment-grade status on Monday after Moody’s Ratings upgraded the global cruise operator’s credit rating on a strong demand outlook and better credit metrics. Moody’s upgraded the cruise line one notch to Baa3, its lowest high-grade rating, from Ba1, its highest junk grade, according to a Monday statement. The action follows a similar move from S&P Global Ratings, which in February elevated Royal Caribbean to its lowest rung of investment-grade status.

See omnystudio.com/listener for privacy information.